#testing
gm everyone !! I hope everyone is feeling well today !! Sadly I have to take a 4 hour test today so wish me the best of luck !! Also make sure you’ve rested well !! Ate a hearty breakfast !! And do something you love !! <333333 and always remember ilysm <33333333
Sorry for being MIA! I’ve been battling with my health for a while. I may finally have a new diagnosis for what’s been going on!
Credit: Plum Brooke
The Orion spacecraft for NASA’s Artemis I mission has successfully completed several months of simulated space environment System level testing in the NASA-owned thermal vacuum chamber at Plum Brook Station in Ohio, USA.
The testing phase was split into two phases - a 47 day thermal vacuum test and a 14 day electromagnetic compatibility, followed by an interference test in ambient conditions which both simulate the conditions the spacecraft will encounter during its voyage to the Moon and back to Earth.
‘Today marked an important milestone for the Artemis I mission to the Moon,’ said Airbus Head of Space Exploration, Andreas Hammer.
‘We proved to our customers ESA and NASA that the European Service Module, designed and built by our engineers in Bremen – supported by companies in 10 European countries - meets the requirements to withstand the harsh conditions in space.
‘The Artemis programme will land the first woman and next man on the Moon and bring them back safely to Earth, we are proud to contribute to this endeavour with all our know-how, expertise and passion.’
Pleased with the results of this crucial test, the engineering teams from Airbus, the European Space Agency (ESA), Lockheed Martin and NASA have proved the spacecraft is suitable to navigate safely through the extreme conditions that it will experience in space.
Orion will be transported back to the Kennedy Space Center to undergo further testing and prepare the spacecraft for integration with the Space Launch System rocket, beginning the next era of exploration.
Artemis I will travel around the Moon and back to Earth. Airbus in Bremen is already building the second Orion Service Module for Artemis II, where
SpaceX Crew Dragon In-Flight Abort.
Here is a roundup on some of the most recent research and scientific efforts against the coronavirus.
Novartis:
Novartis has reached an agreement with the US Food and Drug Administration to proceed with a phase III clinical trial of hydroxychloroquine in hospitalized Covid-19 patients. The large trial will be conducted at more than a dozen sites in the US and tested on approximately 440 patients to evaluate the use for this treatment.
Additionally, Norvatis plans to make its hydroxychloroquine intellectual property available to support broad access to hydroxychloroquine. Read more here.
Causaly
Causaly, an innovative technology company that harnesses AI to interpret vast databases of biomedical knowledge, is collaborating with UCL academics to increase research on potential therapeutic agents and the identification of biomarkers.
Several researchers and research groups within UCL have been granted access to Causaly technology, allowing them the access to rapidly analyse and derive insights from biomedical literature.
Read more here.
Vaccine Taskforce
As part of the UK’s wider efforts to support the development of a vaccine, a new government-led Vaccine Taskforce will soon be launched to drive forward the manufacturing and research efforts to fight the virus.
The government will review regulations to facilitate fast and safe vaccine trials, as well as operational plans, to ensure a vaccine can be produced at a large scale when it becomes available. Industry and academic institutions will be given the resources and support needed.
Business Secretary Alok Sharma said, ‘UK scientists are working as fast as they can to find a vaccine that fights coronavirus, saving and protecting people’s lives. We stand firmly behind them in their efforts. The Vaccine Taskforce is key to coordinating efforts to rapidly accelerate the development and manufacture of a potential new vaccine.’ Read more here.
A new biosensor for the COVID-19 virus
Research teams at Empa and ETH Zurich have developed an alternative test method in the form of an optical biosensor. The sensor made up of gold nanostructure, known as gold nonoislands on a glass substrate, combines two different effects to detect covid-19: an optical and a thermal one.
According to the release, ‘Artificially produced DNA receptors that match specific RNA sequences of the SARS-CoV-2 [virus] are grafted onto the nanoislands,’ and researchers will then use the optical phenomena, - localised surface plasmon resonance - to monitor the presence of the virus.
The biosensor is not yet ready to be used to monitor and detect COVID-19, however tests showed the sensor can distinguish between very similar RNA sequences of SARS-CoV-2 virus and its relative, SARS-Cov. Read more here.
For more information and more updates on the coronavirus, please visit our hubhere.
fun fact
my name was misspelt on the SAT form and my school had to CALL THE COLLEGE BOARD just to get it changed wild man this happened last week but i remembered today while taking the SAT because my name was right on the sheet
TESTING.
About to test these gouache paints!
This has been a test
Does studying music boost students’ overall test scores? Recent research casts doubt on that belief, concluding that the link between music education and good grades appears to reflect the impressive nature of the students who study music, rather than an intrinsic effect of the lessons themselves.
But a new study from Canada suggests music lessons may in fact have wide-ranging intellectual benefits. It finds that, among a group of high-performing high school students, grades were consistently higher for those who continued music classes compared to those who dropped them after two years of compulsory training.